Tennessee Valley Cooperative Human Tissue Network

田纳西谷合作人体组织网络

• 批准号: 9247707
• 负责人: MARY Kay WASHINGTON
• 金额: $ 98.9万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-01 至 2019-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9247707
• 关键词: Advocate; Awareness; Basic Science; Biomedical Research; Businesses; Clinical; Collection; Communication; Communities; Complex; Computer software; Confidentiality of Patient Information; Cooperative Human Tissue Network; DNA; Data Set; Development; Disease; Education; Funding; Generations; Goals; Healthcare; Human; Informatics; Informed Consent; Link; Malignant Neoplasms; Marketing; Modeling; Modernization; Patients; Play; Procedures; Process; Public Health; Quality Control; RNA; Rare Lesion; Recording of previous events; Research; Research Personnel; Resources; Role; Services; Solid; Source; Specimen; System; Tennessee; Tissue Microarray; Tissue Sample; Tissues; Translational Research; biobank; cost effective; experience; human disease; human tissue; improved; individual patient; innovation; member; neoplastic; operation; programs; prospective; public health relevance; tumor; tumor progression; web services

DESCRIPTION (provided by applicant): The Cooperative Human Tissue Network (CHTN) has played an important role since 1987 as a source of human tissues to support biomedical research. As the Western Division of the CHTN, we propose to continue to serve the scientific community by procuring and distributing biospecimens in an efficient, cost-effective manner. The specific aims of this application are: 1) To collect, process and distribute high quality human solid tissue and biofluid specimens with appropriate clinical annotation to qualified researchers on a prospective basis; 2) To apply a rigorous Quality Management System to all aspects of the program; 3) To provide tumor macrodissection, tissue microarray "build on demand" and RNA/DNA extraction services, as requested; 4) To collect and bank pre-neoplastic and rare lesions to facilitate basic research in tumor progression and early translational research; 5) To protect patient confidentiality by obtaining informed consent for collection of extraneous tissue and biofluids for research, and through de-identification of specimens, and by continuing to partner with VUMC patient advocates to engage patients and provide opportunities for participation in research; 6) To develop and integrate new business models and informatics (IT) strategies that improve operational efficiency, by developing a third generation network Investigator IT system for request sharing; 7) To develop innovative internal IT programs by partnering with VUMC BioVu project to link tissue samples to large clinical datasets, and by providing an internal mechanism for research results sharing at VUMC as a pilot program; 8) To expand CHTN marketing and education efforts through strategies to increase awareness in the scientific community. In 12 years as a CHTN Division, we have been an innovative and highly productive member of the network, distributing over 63,170 specimens to 723 investigators in the last 5 years. We have developed critical SOPs and integrative biorepository software that have been implemented throughout the CHTN. Our goals in the next funding period include continuing to provide numerous high quality biospecimens and to develop innovative IT programs to improve efficiency and communication within the network and with investigators.

描述（由申请人提供）：自1987年以来，合作人体组织网络（CHTN）作为支持生物医学研究的人体组织来源发挥了重要作用。作为香港卫生中心西区分部，我们建议继续以高效率和具成本效益的方式，采购和分发生物标本，为科学界服务。本应用程序的具体目的是：1)收集、加工和分配高质量的人力资源